TC BioPharm shares are trading lower after the company announced an ADS ratio change from 1 ADS representing 20 ordinary shares to 1 ADS representing 200 ordinary shares.
Portfolio Pulse from Benzinga Newsdesk
TC BioPharm shares are trading lower after the company announced a change in its ADS ratio from 1 ADS representing 20 ordinary shares to 1 ADS representing 200 ordinary shares.

July 31, 2024 | 6:53 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
TC BioPharm shares are trading lower following the announcement of a change in its ADS ratio from 1 ADS representing 20 ordinary shares to 1 ADS representing 200 ordinary shares.
The change in ADS ratio is likely perceived negatively by investors, leading to a drop in share price. Such changes can often signal underlying issues or a need to adjust the stock's marketability.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100